HIV-Associated Neurocognitive Disorders: Perspective on Management Strategies
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
HIV-Associated Neurocognitive Disorders: Perspective on Management Strategies
Authors
Keywords
Human Immunodeficiency Virus, Atazanavir, Human Immunodeficiency Virus Patient, Darunavir, Maraviroc
Journal
DRUGS
Volume 73, Issue 9, Pages 893-905
Publisher
Springer Nature
Online
2013-06-03
DOI
10.1007/s40265-013-0059-6
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Etravirine in CSF is highly protein bound
- (2013) A. Nguyen et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- The Alzheimer’s disease-8 and Montreal Cognitive Assessment as screening tools for neurocognitive impairment in HIV-infected persons
- (2013) Edgar Turner Overton et al. JOURNAL OF NEUROVIROLOGY
- HIV-1-Related Central Nervous System Disease: Current Issues in Pathogenesis, Diagnosis, and Treatment
- (2013) S. Spudich et al. Cold Spring Harbor Perspectives in Medicine
- Lower than expected maraviroc concentrations in cerebrospinal fluid exceed the wild-type CC chemokine receptor 5-tropic HIV-1 50% inhibitory concentration
- (2012) David Croteau et al. AIDS
- Determinants of darunavir cerebrospinal fluid concentrations
- (2012) Andrea Calcagno et al. AIDS
- Therapeutic Amprenavir Concentrations in Cerebrospinal Fluid
- (2012) David Croteau et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Assessment, Diagnosis, and Treatment of HIV-Associated Neurocognitive Disorder: A Consensus Report of the Mind Exchange Program
- (2012) et al. CLINICAL INFECTIOUS DISEASES
- Low Cerebrospinal Fluid Concentrations of the Nucleotide HIV Reverse Transcriptase Inhibitor, Tenofovir
- (2012) Brookie M. Best et al. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
- Higher CNS Penetration-Effectiveness of Long-term Combination Antiretroviral Therapy Is Associated With Better HIV-1 Viral Suppression in Cerebrospinal Fluid
- (2012) Alexia Cusini et al. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
- Etravirine concentrations in CSF in HIV-infected patients
- (2012) J. M. Tiraboschi et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Darunavir is predominantly unbound to protein in cerebrospinal fluid and concentrations exceed the wild-type HIV-1 median 90% inhibitory concentration
- (2012) D. Croteau et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Role of obesity, metabolic variables, and diabetes in HIV-associated neurocognitive disorder
- (2012) J. A. McCutchan et al. NEUROLOGY
- Tenofovir and emtricitabine cerebrospinal fluid-to-plasma ratios correlate to the extent of blood-brainbarrier damage
- (2011) Andrea Calcagno et al. AIDS
- CNS effects of a CCR5 inhibitor in HIV-infected subjects: a pharmacokinetic and cerebral metabolite study
- (2011) L. Garvey et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Hepatitis C virus co-infection increases neurocognitive impairment severity and risk of death in treated HIV/AIDS
- (2011) Pornpun Vivithanaporn et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- Minocycline treatment for HIV-associated cognitive impairment: Results from a randomized trial
- (2011) N. Sacktor et al. NEUROLOGY
- The burden of HIV-associated neurocognitive impairment in Australia and its estimates for the future
- (2011) Lucette A. Cysique et al. Sexual Health
- Effects of central nervous system antiretroviral penetration on cognitive functioning in the ALLRT cohort
- (2010) Marlene Smurzynski et al. AIDS
- Editorial NeuroAIDS review
- (2010) Paul Shapshak et al. AIDS
- Total Raltegravir Concentrations in Cerebrospinal Fluid Exceed the 50-Percent Inhibitory Concentration for Wild-Type HIV-1
- (2010) D. Croteau et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Discordance Between Cerebral Spinal Fluid and Plasma HIV Replication in Patients with Neurological Symptoms Who Are Receiving Suppressive Antiretroviral Therapy
- (2010) Ana Canestri et al. CLINICAL INFECTIOUS DISEASES
- Therapy Failure following Selection of Enfuvirtide‐Resistant HIV‐1 in Cerebrospinal Fluid
- (2010) S. F. L. van Lelyveld et al. CLINICAL INFECTIOUS DISEASES
- Neurocognitive functioning in HIV-1 infection: effects of cerebrovascular risk factors and age
- (2010) Jessica Foley et al. CLINICAL NEUROPSYCHOLOGIST
- Memantine for AIDS Dementia Complex: Open-Label Report of ACTG 301
- (2010) Yu Zhao et al. HIV CLINICAL TRIALS
- Maraviroc Concentrations in Cerebrospinal Fluid in HIV-Infected Patients
- (2010) Juan Manuel Tiraboschi et al. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
- Efavirenz concentrations in CSF exceed IC50 for wild-type HIV
- (2010) B. M. Best et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- HIV-Associated Neurocognitive Disorder: Pathogenesis and Therapeutic Opportunities
- (2010) Kathryn A. Lindl et al. Journal of Neuroimmune Pharmacology
- HIV-associated neurocognitive disorders before and during the era of combination antiretroviral therapy: differences in rates, nature, and predictors
- (2010) Robert K. Heaton et al. JOURNAL OF NEUROVIROLOGY
- HIV-associated neurocognitive disorders persist in the era of potent antiretroviral therapy: CHARTER Study
- (2010) R. K. Heaton et al. NEUROLOGY
- Molecular mechanisms of neuroinvasion by monocytes-macrophages in HIV-1 infection
- (2010) Gabriel Gras et al. Retrovirology
- Nanotechnology applications for improved delivery of antiretroviral drugs to the brain
- (2009) Ho Lun Wong et al. ADVANCED DRUG DELIVERY REVIEWS
- Cerebrospinal fluid maraviroc concentrations in HIV-1 infected patients
- (2009) Aylin Yilmaz et al. AIDS
- Impact of combination antiretroviral therapy on cerebrospinal fluid HIV RNA and neurocognitive performance
- (2009) Christina M Marra et al. AIDS
- Darunavir Concentrations in Cerebrospinal Fluid and Blood in HIV-1–Infected Individuals
- (2009) Aylin Yilmaz et al. AIDS RESEARCH AND HUMAN RETROVIRUSES
- Lopinavir Cerebrospinal Fluid Steady-State Trough Concentrations in HIV-Infected Adults
- (2009) Robert DiCenzo et al. ANNALS OF PHARMACOTHERAPY
- The transport of anti-HIV drugs across blood–CNS interfaces: Summary of current knowledge and recommendations for further research
- (2009) Lavanya Varatharajan et al. ANTIVIRAL RESEARCH
- Selegiline and oxidative stress in HIV-associated cognitive impairment
- (2009) G. Schifitto et al. NEUROLOGY
- Raltegravir Cerebrospinal Fluid Concentrations in HIV-1 Infection
- (2009) Aylin Yilmaz et al. PLoS One
- The complexities of antiretroviral drug–drug interactions: role of ABC and SLC transporters
- (2009) Olena Kis et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Low atazanavir concentrations in cerebrospinal fluid
- (2008) Brookie M Best et al. AIDS
- Validation of the CNS Penetration-Effectiveness Rank for Quantifying Antiretroviral Penetration Into the Central Nervous System
- (2008) Scott Letendre ARCHIVES OF NEUROLOGY
- Cognitive Dysfunction and Diabetes Mellitus
- (2008) Christopher T. Kodl et al. ENDOCRINE REVIEWS
- Aging exacerbates extrapyramidal motor signs in the era of highly active antiretroviral therapy
- (2008) Victor Valcour et al. JOURNAL OF NEUROVIROLOGY
- Modulation of P-Glycoprotein at the Blood-Brain Barrier: Opportunities to Improve Central Nervous System Pharmacotherapy
- (2008) D. S. Miller et al. PHARMACOLOGICAL REVIEWS
- Seizure-Induced Up-Regulation of P-Glycoprotein at the Blood-Brain Barrier through Glutamate and Cyclooxygenase-2 Signaling
- (2007) B. Bauer et al. MOLECULAR PHARMACOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation